Ali Akbar Alizadeh
1,2,3,4, Maryam Hamzeh-Mivehroud
5,2,4, Siavoush Dastmalchi
2,4*1 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
4 School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
5 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Purpose: Tumor
necrosis factor alpha (TNF-α) is an inflammatory cytokine, involved in both
physiological and pathological pathways. Because of central role of TNF-α in
pathogenesis of inflammatory diseases, in
the current study, we aimed to identify novel scFv antibodies against TNF-α
using phage display technology.
Methods: Using
libraries composed of phagemid displaying scFv antibodies, four rounds of
biopanning against TNF-α were carried out, which led to identification of scFvs
capable of binding to TNF-α. The scFv antibody with appropriate binding
affinity towards TNF-α, was amplified and used in ELISA experiment.
Results: Titration of phage achieved from different
rounds of biopanning showed an enrichment of specific anti-TNF-α phages during
biopanning process. Using ELISA experiment, a binding constant (Kd) of 1.11 ± 0.32 nM was determined for the phage displaying
J48 scFv antibody.
Conclusion: The findings in the
current work revealed that the identified novel scFv antibody displayed at the
N-terminal of minor coat proteins of phagemid binds TNF-α with suitable
affinity. However, the soluble form of the antibody is needed to be produced
and evaluated in more details regarding its binding properties to TNF-α.